Compare Definium Therapeutics Inc. Common Shares (DFTX) vs SpaceX (SPCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs SpaceX — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.45 (market cap $4.59B), while SpaceX trades at $166.98 (market cap $2.18T). The key difference: SpaceX is far larger — about 474.9× Definium Therapeutics Inc. Common Shares's market cap, and SpaceX is more actively traded (68,508,567 versus 2,103,937). Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and SpaceX for 41 Days on average.
| DFTX | SPCX | |
|---|---|---|
Market Cap | $4.59B | $2.18T |
Volume | 2,103,937 | 68,508,567 |
Sector | Health | Industrials |
52-Week High | $48.45 | $202.09 |
52-Week Low | $10.68 | $108.27 |
Typical Hold Time | 0 Days | 41 Days |
Enterprise Value | $3.55B | $2.12T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About SpaceX
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →
